| Literature DB >> 33604584 |
Andrew Y Lin1, Florentino Lupercio1, Gordon Ho1, Travis Pollema2, Victor Pretorius2, Ulrika Birgersdotter-Green1.
Abstract
BACKGROUND: Transvenous lead extraction of cardiovascular implantable electronic device (CIED) has been proven safe in the general patient population with the advances in extraction techniques. Octogenarians present a unique challenge given their comorbidities and the perceived increase in morbidity and mortality.Entities:
Keywords: cardiovascular implantable electronic device; implantable cardioverter-defibrillator; octogenarian; pacemaker; transvenous lead extraction
Year: 2020 PMID: 33604584 PMCID: PMC7889020 DOI: 10.1016/j.hroo.2020.07.005
Source DB: PubMed Journal: Heart Rhythm O2 ISSN: 2666-5018
Figure 1Selection of studies.
Patient demographics and characteristics
| Study | Rodriguez et al | Williams et al | Pelargonio et al | Kempa et al | Kutarski et al | El-Chami et al | Yagishita et al | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | |
| Patients | 118 | 388 | 72 | 334 | 150 | 699 | 26 | 134 | 192 | 1060 | 100 | 674 | 51 | 184 |
| Age, y | 85±4 | 64±12 | 84±3 | 62±14 | 84±3 | 61±10 | 84±3 | 60±14 | 83±3 | 63±13 | 85±4 | 60±15 | 86±5 | 67±15 |
| Male | 78 (66) | 301 (78) | 53 (74) | 258 (77) | 96 (64) | 556 (80) | 16 (62) | 97 (72) | 105 (55) | 669 (63) | 63 (63) | 446 (66) | 34 (68) | 133 (73) |
| Lead age, mo | 60±53 | 39±44 | 71 | 74 | 42 | 29 | 55 | 40 | 76 | 84 | 71 | 67 | 110 | 88 |
| EF | 42±17 | 35±19 | 42±14 | 45±13 | 49±13 | 42±14 | 44±10 | 40±15 | NR | NR | 43±15 | 36±17 | 57±15 | 54±16 |
| Device type | ||||||||||||||
| PPM | 68 (56) | 141 (36) | 46 (64) | 172 (51) | 126 (84) | 385 (55) | 24 (92) | 67 (50) | 147 (77) | 593 (56) | 36 (36) | 70 (10) | 42 (82) | 93 (51) |
| ICD | 35 (28) | 181 (47) | 11 (15) | 96 (29) | 24 (16) | 314 (45) | 2 (8) | 63 (47) | 14 (7) | 305 (29) | 48 (48) | 496 (74) | 3 (6) | 63 (34) |
| CRT-P | 2 (3) | 1 (1) | 1 (1) | 20 (6) | Bi-V: | Bi-V: | Bi-V: | Bi-V: | Bi-V: | Bi-V: | Bi-V | Bi-V: | 3 (6) | 4 (2) |
| CRT-D | 13 (13) | 65 (16) | 14 (19) | 46 (14) | 38 | 170 | 0 (0) | 4 (3) | 31 (16) | 162 (15) | 16 (16) | 108 (16) | 3 (6) | 24 (13) |
| Indications | ||||||||||||||
| Infection | 99 (84) | 296 (76) | 58 (80) | 207 (62) | 133 (89) | 573 (82) | 15 (58) | 64 (48) | 102 (53) | 448 (42) | 47 (47) | 225 (33) | 50 (98) | 116 (63) |
| Lead failure | 17 (14) | 84 (21) | 9 (13) | 96 (29) | NR | NR | 6 (23) | 56 (42) | NR | NR | 39 (39) | 339 (50) | 1 (2) | 49 (27) |
| Device upgrade | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 7 (7) | 64 (10) | 0 (0) | 9 (5) |
| SVC syndrome | NR | NR | 1 (1) | 3 (1) | NR | NR | 0 (0) | 2 (1) | NR | NR | NR | NR | 0 (0) | 2 (1) |
| Chronic pain | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 0 (0) | 2 (1) |
| Other | NR | NR | 4 (6) | 28 (8) | NR | NR | 5 (19) | 12 (9) | NR | NR | 7 (7) | 46 (7) | 0 (0) | 6 (3) |
| Comorbidities | ||||||||||||||
| HTN | 104 (88) | 324 (84) | 25 (41) | 89 (30) | 122 (81) | 502 (72) | 16 (62) | 61 (46) | NR | NR | 77 (77) | 411 (61) | 27 (53) | 70 (38) |
| DM | 45 (38) | 190 (49) | 6 (10) | 30 (10) | 60 (40) | 222 (32) | 11 (42) | 37 (28) | NR | NR | 19 (19) | 206 (31) | 13 (26) | 40 (22) |
| CAD | 72 (61) | 261 (67) | 35 (57) | 117 (38) | 41 (27) | 264 (38) | 12 (47) | 60 (45) | NR | NR | 50 (50) | 265 (39) | 10 (20) | 31 (17) |
| CKD | 26 (22) | 84 (22) | 12 (18) | 44 (14) | 83 (55) | 182 (26) | 4 (15) | 21 (16) | NR | NR | 25 (25) | 131 (19) | 3 (6) | 7 (4) |
| CVA | NR | NR | 8 (13) | 18 (6) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| COPD | NR | NR | 7 (12) | 28 (9) | 69 (46) | 133 (19) | NR | NR | NR | NR | NR | NR | NR | NR |
Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables.
Bi-V = biventricular; CAD = coronary artery disease; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; CRT-D = cardiac resynchronization therapy defibrillator; CRT-P = cardiac resynchronization therapy pacemaker; CVA = cerebrovascular accident; DM = diabetes mellitus; EF = ejection fraction; HTN = hypertension; ICD = implantable cardioverter-defibrillator; NR = not reported; PPM = permanent pacemaker; SVC = superior vena cava.
Study characteristics
| Study | Rodriguez et al | Williams et al | Pelargonio et al | Kempa et al | Kutarski et al | El-Chami et al | Yagishita et al |
|---|---|---|---|---|---|---|---|
| Study design | Retrospective | Retrospective | Retrospective | Retrospective | Retrospective | Retrospective | Retrospective |
| Years of extraction | 2004–2009 | 2001–2011 | 2005–2011 | 2003–2011 | 2006–2013 | 2007–2016 | 2013–2018 |
| Year of publication | 2011 | 2012 | 2012 | 2012 | 2013 | 2017 | 2019 |
| Study site | Single center | Single center | Multicenter | Single center | Single center | Single center | Single center |
| Single operator | Yes | No | No | Not reported | Yes | No | Not reported |
| Follow-up | 30 days | At least 30 days | Not reported | Not reported | Not reported | 3 years | Not reported |
Figure 2Forest plot and funnel plot of efficacy outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Complete procedural success. B: Clinical success.
Figure 3Comparative analysis of A: clinical success, B: major complication, and C: minor complication of device extraction in octogenarians vs younger control group.
Figure 4Forest plot and funnel plot of safety outcomes of cardiovascular implantable electronic device extraction in octogenarians vs younger patients. A: Procedural mortality. B: Major complication. C: Minor complication.
Procedural characteristics
| Study | Rodriguez et al | Williams et al | Pelargonio et al | Kempa et al | Kutarski et al | El-Chami et al | Yagishita et al | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | Old | Young | |
| Patients, n | 118 | 388 | 72 | 334 | 150 | 699 | 26 | 134 | 192 | 1060 | 100 | 674 | 51 | 184 |
| Procedure time | NR | NR | 88±53 | 92±52 | NR | NR | NR | NR | 104±46 | 111±48 | NR | NR | NR | NR |
| Technique | ||||||||||||||
| MT | 0 (0) | 0 (0) | 35 (49) | 168 (50) | 26 (17) | 109 (15) | NR | NR | NR | NR | 42 (42) | 277 (41) | 0 (0) | 0 (0) |
| LS | 118 (100) | 388 (100) | 37 (51) | 166 50) | 124 (83) | 578 (83) | NR | NR | NR | NR | 41 (41) | 304 (45) | 44 (86) | 165 (90) |
| MS | 0 (0) | 0 (0) | 0 (0) | 0 (0 0 | 0 (0) | 12 (2) | NR | NR | NR | NR | 17 (17) | 93 (14) | 7 (14) | 19 (10) |
| Leads extracted | ||||||||||||||
| Total | 253 | 814 | 141 | 657 | 301 | 1410 | 35 | 185 | 2137 | 1078 | 170 | NR | NR | |
| Atrial | 99 (39) | 295 (36) | 57 (40) | 254 (39) | 97 (32) | 484 (34) | 12 (34) | 65 (35) | 914 (43) | NR | NR | NR | NR | |
| Ventricular | 145 (57) | 442 (54) | 70 (50) | 344 (52) | 166 (55) | 753 (53) | 23 (66) | 116 (63) | 1145 (54) | NR | NR | NR | NR | |
| CS | 9 (4) | 77 (10) | 14 (10) | 59 (9) | 38 (13) | 173 (13) | 0 (0) | 4 (2) | 78 (3) | NR | NR | NR | NR | |
| Approach | ||||||||||||||
| Subclavian | 116 (98) | 379 (98) | 70 (97) | 331 (97) | NR | NR | 25 (96) | 131 (98) | NR | NR | 96 (96) | 640 (95) | NR | NR |
| Femoral | 2 (2) | 9 (2) | 2 (3) | 11 (3) | NR | NR | 1 (4) | 3 (2) | NR | NR | 4 (4) | 34 (5) | NR | NR |
Values presented as mean ± standard deviation for continuous variables and number (percentage) for categorical variables.
CS = coronary sinus; LS = laser sheath; MS = mechanical sheath; MT = manual traction; NR = not reported.
Newcastle-Ottawa scale of the included studies
| Study | Selection | Comparability | Outcome |
|---|---|---|---|
| Rodriguez et al | 3 | 1 | 2 |
| Williams et al | 3 | 1 | 3 |
| Pelargonio et al | 3 | 1 | 3 |
| Kempa et al | 3 | 1 | 2 |
| Kutarski et al | 3 | 2 | 3 |
| El-Chami et al | 3 | 1 | 3 |
| Yagishita et al | 3 | 1 | 3 |
Maximum 4 stars.
Maximum 2 stars.
Maximum 3 stars.